175 related articles for article (PubMed ID: 28241454)
1. Next-Generation Sequencing Approach in Methylation Analysis of HNF1B and GATA4 Genes: Searching for Biomarkers in Ovarian Cancer.
Bubancova I; Kovarikova H; Laco J; Ruszova E; Dvorak O; Palicka V; Chmelarova M
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241454
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
[TBL] [Abstract][Full Text] [Related]
3. Importance of promoter methylation of GATA4 gene in epithelial ovarian cancer.
Chmelarova M; Dvorakova E; Spacek J; Laco J; Palicka V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):294-7. PubMed ID: 24145767
[TBL] [Abstract][Full Text] [Related]
4. Importance of Cadherins Methylation in Ovarian Cancer: a Next Generation Sequencing Approach.
Chmelarova M; Baranova I; Ruszova E; Laco J; Hrochova K; Dvorakova E; Palicka V
Pathol Oncol Res; 2019 Oct; 25(4):1457-1465. PubMed ID: 30368729
[TBL] [Abstract][Full Text] [Related]
5. Identification of a four-gene methylation biomarker panel in high-grade serous ovarian carcinoma.
Baranova I; Kovarikova H; Laco J; Sedlakova I; Vrbacky F; Kovarik D; Hejna P; Palicka V; Chmelarova M
Clin Chem Lab Med; 2020 Jul; 58(8):1332-1340. PubMed ID: 32145055
[TBL] [Abstract][Full Text] [Related]
6. Importance of promoter methylation of GATA4 and TP53 genes in endometrioid carcinoma of endometrium.
Chmelarova M; Kos S; Dvorakova E; Spacek J; Laco J; Ruszova E; Hrochova K; Palicka V
Clin Chem Lab Med; 2014 Aug; 52(8):1229-34. PubMed ID: 24651021
[TBL] [Abstract][Full Text] [Related]
7. HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer.
Ross-Adams H; Ball S; Lawrenson K; Halim S; Russell R; Wells C; Strand SH; Ørntoft TF; Larson M; Armasu S; Massie CE; Asim M; Mortensen MM; Borre M; Woodfine K; Warren AY; Lamb AD; Kay J; Whitaker H; Ramos-Montoya A; Murrell A; Sørensen KD; Fridley BL; Goode EL; Gayther SA; Masters J; Neal DE; Mills IG
Oncotarget; 2016 Nov; 7(46):74734-74746. PubMed ID: 27732966
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers.
Huang RL; Gu F; Kirma NB; Ruan J; Chen CL; Wang HC; Liao YP; Chang CC; Yu MH; Pilrose JM; Thompson IM; Huang HC; Huang TH; Lai HC; Nephew KP
Epigenetics; 2013 Jun; 8(6):624-34. PubMed ID: 23774800
[TBL] [Abstract][Full Text] [Related]
9. Expression, Epigenetic, and Genetic Changes of HNF1B in Colorectal Lesions: an Analysis of 145 Cases.
Bártů M; Hojný J; Hájková N; Michálková R; Krkavcová E; Simon K; Frýba V; Stružinská I; Němejcová K; Dundr P
Pathol Oncol Res; 2020 Oct; 26(4):2337-2350. PubMed ID: 32488808
[TBL] [Abstract][Full Text] [Related]
10. Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival.
Zhou F; Tao G; Chen X; Xie W; Liu M; Cao X
Clin Chem Lab Med; 2014 May; 52(5):735-42. PubMed ID: 24327526
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.
Shen H; Fridley BL; Song H; Lawrenson K; Cunningham JM; Ramus SJ; Cicek MS; Tyrer J; Stram D; Larson MC; Köbel M; ; Ziogas A; Zheng W; Yang HP; Wu AH; Wozniak EL; Woo YL; Winterhoff B; Wik E; Whittemore AS; Wentzensen N; Weber RP; Vitonis AF; Vincent D; Vierkant RA; Vergote I; Van Den Berg D; Van Altena AM; Tworoger SS; Thompson PJ; Tessier DC; Terry KL; Teo SH; Templeman C; Stram DO; Southey MC; Sieh W; Siddiqui N; Shvetsov YB; Shu XO; Shridhar V; Wang-Gohrke S; Severi G; Schwaab I; Salvesen HB; Rzepecka IK; Runnebaum IB; Rossing MA; Rodriguez-Rodriguez L; Risch HA; Renner SP; Poole EM; Pike MC; Phelan CM; Pelttari LM; Pejovic T; Paul J; Orlow I; Omar SZ; Olson SH; Odunsi K; Nickels S; Nevanlinna H; Ness RB; Narod SA; Nakanishi T; Moysich KB; Monteiro AN; Moes-Sosnowska J; Modugno F; Menon U; McLaughlin JR; McGuire V; Matsuo K; Adenan NA; Massuger LF; Lurie G; Lundvall L; Lubiński J; Lissowska J; Levine DA; Leminen A; Lee AW; Le ND; Lambrechts S; Lambrechts D; Kupryjanczyk J; Krakstad C; Konecny GE; Kjaer SK; Kiemeney LA; Kelemen LE; Keeney GL; Karlan BY; Karevan R; Kalli KR; Kajiyama H; Ji BT; Jensen A; Jakubowska A; Iversen E; Hosono S; Høgdall CK; Høgdall E; Hoatlin M; Hillemanns P; Heitz F; Hein R; Harter P; Halle MK; Hall P; Gronwald J; Gore M; Goodman MT; Giles GG; Gentry-Maharaj A; Garcia-Closas M; Flanagan JM; Fasching PA; Ekici AB; Edwards R; Eccles D; Easton DF; Dürst M; du Bois A; Dörk T; Doherty JA; Despierre E; Dansonka-Mieszkowska A; Cybulski C; Cramer DW; Cook LS; Chen X; Charbonneau B; Chang-Claude J; Campbell I; Butzow R; Bunker CH; Brueggmann D; Brown R; Brooks-Wilson A; Brinton LA; Bogdanova N; Block MS; Benjamin E; Beesley J; Beckmann MW; Bandera EV; Baglietto L; Bacot F; Armasu SM; Antonenkova N; Anton-Culver H; Aben KK; Liang D; Wu X; Lu K; Hildebrandt MA; ; ; Schildkraut JM; Sellers TA; Huntsman D; Berchuck A; Chenevix-Trench G; Gayther SA; Pharoah PD; Laird PW; Goode EL; Pearce CL
Nat Commun; 2013; 4():1628. PubMed ID: 23535649
[TBL] [Abstract][Full Text] [Related]
12. GATA4 and DcR1 methylation in glioblastomas.
Vaitkienė P; Skiriutė D; Skauminas K; Tamašauskas A
Diagn Pathol; 2013 Jan; 8():7. PubMed ID: 23320456
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation of GATA4, WIF1, NTRK1 and other selected tumour suppressor genes in ovarian cancer.
Chmelařová M; Dvořáková E; Špaček J; Laco J; Mžik M; Palička V
Folia Biol (Praha); 2013; 59(2):87-92. PubMed ID: 23746174
[TBL] [Abstract][Full Text] [Related]
14. Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis.
Cuff J; Salari K; Clarke N; Esheba GE; Forster AD; Huang S; West RB; Higgins JP; Longacre TA; Pollack JR
PLoS One; 2013; 8(9):e74562. PubMed ID: 24040285
[TBL] [Abstract][Full Text] [Related]
15. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive quantitative analysis of alternative splicing variants reveals the HNF1B mRNA splicing pattern in various tumour and non-tumour tissues.
Hojny J; Michalkova R; Krkavcova E; Bui QH; Bartu M; Nemejcova K; Kalousova M; Kleiblova P; Dundr P; Struzinska I
Sci Rep; 2022 Jan; 12(1):199. PubMed ID: 34997048
[TBL] [Abstract][Full Text] [Related]
17. Leptin Protein Expression and Promoter Methylation in Ovarian Cancer: A Strong Prognostic Value with Theranostic Promises.
Assidi M; Yahya FM; Al-Zahrani MH; Elkhatib R; Zari A; Elaimi A; Al-Maghrabi J; Dallol A; Buhmeida A; Abu-Elmagd M
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884678
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients--a study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD).
Ruscito I; Dimitrova D; Vasconcelos I; Gellhaus K; Schwachula T; Bellati F; Zeillinger R; Benedetti-Panici P; Vergote I; Mahner S; Cacsire-Tong D; Concin N; Darb-Esfahani S; Lambrechts S; Sehouli J; Olek S; Braicu EI
Eur J Cancer; 2014 Aug; 50(12):2090-8. PubMed ID: 24889916
[TBL] [Abstract][Full Text] [Related]
19. HNF1B, EZH2 and ECI2 in prostate carcinoma. Molecular, immunohistochemical and clinico-pathological study.
Dundr P; Bártů M; Hojný J; Michálková R; Hájková N; Stružinská I; Krkavcová E; Hadravský L; Kleissnerová L; Kopejsková J; Hiep BQ; Němejcová K; Jakša R; Čapoun O; Řezáč J; Jirsová K; Franková V
Sci Rep; 2020 Sep; 10(1):14365. PubMed ID: 32873863
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor promoter methylation predicts survival in low-grade ovarian carcinoma patients.
Kirn V; Shi R; Heublein S; Knabl J; Guenthner-Biller M; Andergassen U; Fridrich C; Malter W; Harder J; Friese K; Mayr D; Jeschke U
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1681-7. PubMed ID: 24908329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
